BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Pseudomonas infection
,
Prostate
,
Nosology
,
Valproic acid
,
rs3825942
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
toll like receptors 9
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Skin of mice with IL23-induced psoriasis-like phenotype treated with TLR7/8/9 antagonists
B cell-like diffuse large B cell lymphoma TMD8 cells with TLR7 or TLR9 shRNA knockdown
Hemophagocytes isolated from spleens after CpG1826 and anti-IL10R treatment
Bone marrow dendritic cells from recombinent and wildtype mouse strains treated with TLR agonists
Bone marrow derived macrophages and MEFs treated with CpG-ODN 1668, LPS, or IFN-beta
Explore Curated Studies Results
Literature
Most Relevant Literature
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based Nanomaterials.
MTMR3 risk alleles enhance Toll Like Receptor 9-induced IgA immunity in IgA nephropathy.
RETRACTED ARTICLE: Curcumin deactivates M2 macrophages to alleviate lung fibrosis in IgG4-related di…
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.
Electronic Cigarettes Induce Mitochondrial DNA Damage and Trigger TLR9 (Toll-Like Receptor 9)-Mediat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected …
Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chr…
Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Pati…
The Suppression of Toll Like Receptors by Insulin
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ